So there is a possibility the favourable findings for this group of drugs may relate to the people who take them having some additional socioeconomic advantages, including diet, greater or more frequent access to exercise, and maybe higher or longer levels of education, that have also offered some other forms of protection. Martin Whyte, an associate professor at the University of Surrey also added, Notably, the authors did not provide detailed information about the characteristics of patients in each group, either before or after statistical matching, and treatment duration for either GLP-1 drugs or metformin was not reported
Choline 64 mg
The regulatory landscape creates both challenges and opportunities
Sleep is divided into two broad stages: non-rapid eye movement sleep (non-REMS or NREMS) and rapid eye movement sleep (REMS)
In new data from a phase 2 dose-ranging trial, researchers found weight loss continued to increase up to 13 weeks for adults with overweight or obesity
This decrease was mitigated by NAC or Fer-1 treatment (Fig
